Gary Goldberg Planning Services’s Teva Pharmaceuticals TEVA Stock Holding History

Gary Goldberg Planning Services’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$4K	Hold	62	–	–	﹤0.01%	413
2014 Q3	$3K	Hold	62	–	–	﹤0.01%	445
2014 Q2	$3K	Sell	62 -6	-9%	-$307	﹤0.01%	384
2014 Q1	$4K	Buy	68 +6	+10%	+$277	﹤0.01%	364
2013 Q4	$2K	Hold	62	–	–	﹤0.01%	332
2013 Q3	$2K	Hold	62	–	–	﹤0.01%	348
2013 Q2	$2K	Buy	+62	New	+$2.41K	﹤0.01%	354

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Gary Goldberg Planning Services's TEVA Position: Q4 2014 in Review

Gary Goldberg Planning Services held its Teva Pharmaceuticals (TEVA) position steady in Q4 2014 at 62 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #413.

Gary Goldberg Planning Services first reported a position in TEVA in Q2 2013 and has held it in 7 quarters since. 821 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

Gary Goldberg Planning Services held 62 shares of Teva Pharmaceuticals worth $4K as of Q4 2014.
Gary Goldberg Planning Services left its Teva Pharmaceuticals share count unchanged in Q4 2014.
Teva Pharmaceuticals made up ﹤0.01% of Gary Goldberg Planning Services's portfolio in Q4 2014, its #413 holding.
Gary Goldberg Planning Services first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
821 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2014.

Based on Gary Goldberg Planning Services's 13F filing for Q4 2014, filed 9 Feb 2015.